Clinical and experimental hypertension. Part A, Theory and practice 1984-01-01

The blood pressure and metabolic effects of 19-nor-deoxycorticosterone and 19-nor-progesterone in sheep.

C D Spence, J P Coghlan, D A Denton, C E Gomez-Sanchez, E H Mills, M A Nelson, J A Whitworth, B A Scoggins

Index: Clin. Exp. Hypertens. A. 6(9) , 1591-600, (1984)

Full Text: HTML

Abstract

The present study examines the blood pressure and metabolic effects of 5 day infusions of 19-nor-deoxycorticosterone (19-nor-DOC) and 19- nor-progesterone (19-nor-PROG) in the intact conscious sheep. Both these steroids raise blood pressure in the rat. 19-nor-DOC (5 mg/d) produced a significant increase in mean arterial pressure (MAP) of 17 mmHg on day 5 (p less than 0.001), associated with 'mineralocorticoid' effects hypokalaemia, hypernatraemia and an initial urinary sodium retention. In contrast 19-nor-PROG (5 mg/d and 50 mg/d) had no effect on MAP and displayed no 'mineralocorticoid' activity.

Related Compounds

Related Articles:

Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay.

2008-05-01

[J. Steroid Biochem. Mol. Biol. 110(1-2) , 39-47, (2008)]

The pharmacology of nomegestrol acetate.

2012-04-01

[Maturitas 71(4) , 345-53, (2012)]

Interaction of new 19 nor progesterone derivatives with progestagen, mineralocorticoid and glucocorticoid cytosolic receptors.

1986-01-01

[J. Pharmacol. 17(4) , 699-706, (1986)]

19-Nor-corticosteroids in experimental and human hypertension.

1982-01-01

[Clin. Exp. Hypertens. A. 4(9-10) , 1851-67, (1982)]

Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells.

1995-10-01

[J. Steroid Biochem. Mol. Biol. 55(1) , 77-84, (1995)]

More Articles...